Categories: Health

Pembrolizumab: Immunotherapy Drug Can Be Effective In Some Men with Advanced Prostate Cancer

Image source: Keytruda

An immunotherapy drug can be effective in some men with advanced prostate cancer, a major trial has shown.

The phase II clinical trial, led by the Institute of Cancer Research and the Royal Marsden, involved 258 men with advanced prostate cancer who had run out of all other options on treatment.

The men had stopped responding to the main treatment options.

According to researchers, a small proportion of men, described as “super responders”, remained well even after the trial ended, despite a very poor prognosis before treatment.

Last week it was reported the same drug had proved effective in treating advanced head and neck cancers.

Immunotherapy uses our own immune systems to recognize and attack cancer cells.

The therapy is already being used as a standard treatment for some cancers such as melanomas – and being tested on many others too.

Nivolumab: Immunotherapy Drug Hailed as Game-Changer in Cancer Treatment

Bladder cancer breakthrough: New immunotherapy drug for terminal patients

The study found that one in 20 men with advanced prostate cancer responded to the drug pembrolizumab – and saw their tumors actually shrink or disappear altogether.

The study, published in the Journal of Clinical Oncology found that although a relatively small number, some of the men gained years of extra life.

A further 19% saw some evidence of improvement.

Most patients in the study lived for an average of eight months on the drug.

The most dramatic responses were seen in patients whose tumors had mutations in genes involved in repairing DNA.

Researchers are now investigating whether this group might benefit the most from immunotherapy in a larger trial.

But first, a test to pick out who will respond best is needed, so that doctors know which patients to give it to.

The number of people diagnosed with prostate cancer has been rising over the last 10 years.

This is probably because the population is getting older and more people are having PSA tests.

Around 30% of men with advanced or stage four prostate cancer survive their cancer for five years or more after diagnosis.

Last week, a separate trial found the same drug kept some people’s advanced head and neck cancers at bay for an average of two years – five times longer than under chemotherapy.

Both studies are part of a growing body of research suggesting immunotherapy could offer hope to an increasing number of cancer patients.

Kathryn R. Bown

Kathryn - Our health specialist likes to share with the readers the latest news from the field. Nobody understands better than her the relation between healthy mind and healthy body.

Recent Posts

Donald Trump and Elon Musk Celebrate Election Victory at UFC 309

Image source: Wikimedia Commons President-elect Donald Trump celebrated his election victory at the Ultimate Fighting…

1 week ago

White House 2024: Donald Trump Wins, Kamala Harris Calls Him to Concede Election

Millions of voters across the US chose to return Donald Trump to the White House…

3 weeks ago

Who Won? Donald Trump Declares Victory as He Addresses Jubilant Supporters in Florida

Donald Trump declares victory in the US election as he addresses jubilant supporters in Florida.…

3 weeks ago

Stocks Soaring as Donald Trump Closes in on US Victory

Stocks around the world are rising as Donald Trump appears to be on the cusp…

3 weeks ago

Who Won? Kamala Harris Cancels Election Night Party as Path to Victory Narrows

Donald Trump has won Pennsylvania, North Carolina and Georgia and taken a lead over Kamala…

3 weeks ago

Quincy Jones Dead at 91

Quincy Jones, the celebrated musician and producer who worked with Michael Jackson, Frank Sinatra, Ray…

3 weeks ago